The effect of fish oil (FO) on colonic function, immunity,
and
microbiota was investigated in Vibrio parahaemolyticus (Vp)-infected C57BL/6J mice. Mice intragastrically presupplemented
with FO (4.0 mg) significantly reduced Vp infection as evidenced by
stabilizing body weight and reducing disease activity index score
and immune organ ratios. FO minimized colonic pathological damage,
strengthened the mucosal barrier, and sustained epithelial permeability
by increasing epithelial crypt depth, goblet cell numbers, and tight
junctions and inhibiting colonic collagen accumulation and fibrosis
protein expression. Mechanistically, FO enhanced immunity by decreasing
colonic CD3+ T cells, increasing CD4+ T cells,
downregulating the TLR4 pathway, reducing interleukin-17 (IL-17) and
tumor necrosis factor-α, and increasing immune cytokine IL-4
and interferon-γ levels. Additionally, FO maintained colonic
microbiota eubiosis by improving microbial diversity and boosting Clostridium, Akkermansia, and Roseburia growth and their derived propionic acid and butyric acid levels.
Collectively, FO alleviated Vp infection by enriching beneficial colonic
microbiota and metabolites and restoring immune homeostasis.